Key Record Dates
| ClinicalTrials.gov Identifier: | NCT00843440 |
|---|---|
| Brief Title: | Efficacy and Safety of Bevacizumab for the Treatment Hemorrhagic Hereditary Telangiectasia (HHT) Associated With Severe Hepatic Vascular Malformations. Phase II Study (METAFORE) |
| First Submitted : | February 12, 2009 |
| First Submitted that Met QC Criteria : | February 12, 2009 |
| First Posted : | February 13, 2009 (Estimate) |
| Last Update Submitted that Met QC Criteria : | May 29, 2013 |
| Last Update Posted : | May 30, 2013 (Estimate) |